MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

Biochemical and Biophysical Research Communications

Volumn 383, Issue 3, 2009, Pages 280-285

  Li, Tao ^a   Li, Dong ^a   Sha, Jianjun ^a   Sun, Peng ^a   Huang, Yiran ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Invasion; MARCKS; miR 21; Prostate cancer

Indexed keywords

ALPHA TROPOMYOSIN; ANDROGEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; MARCKS PROTEIN; MICRORNA; MICRORNA 21; PROTEIN PDCD4; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN TARGETING;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS;

EID: 67349254469     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.077     Document Type: Article

References (28)

1. Krichevsky A.M., and Gabriely G. miR-21: a small multi-faceted RNA. J. Cell Mol. Med. 13 (2009) 39-53
2. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., and Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007) 647-658
3. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., and Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27 (2008) 2128-2136
4. Connolly E., Melegari M., Landgraf P., Tchaikovskaya T., Tennant B.C., Slagle B.L., Rogler L.E., Zavolan M., Tuschl T., and Rogler C.E. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am. J. Pathol. 173 (2008) 856-864
5. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., and Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283 (2008) 1026-1033
6. Si M.L., Zhu S., Wu H., Lu Z., Wu F., and Mo Y.Y. miR-21-mediated tumor growth. Oncogene 26 (2007) 2799-2803
7. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., Linsley P.S., and Krichevsky A.M. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 28 (2008) 5369-5380
8. Damber J.E., and Aus G. Prostate cancer. Lancet 371 (2008) 1710-1721
9. Santos A.F., Huang H., and Tindall D.J. The androgen receptor: a potential target for therapy of prostate cancer. Steroids 69 (2004) 79-85
10. Marcelli M., Marani M., Li X., Sturgis L., Haidacher S.J., Trial J.A., Mannucci R., Nicoletti I., and Denner L. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine, induced apoptosis, expression of Bcl-2 family members-and caspase activation. Prostate 42 (2000) 260-273
11. Arbuzova A., Schmitz A.A., and Vergeres G. Cross-talk unfolded: MARCKS proteins. Biochem. J. 362 (2002) 1-12
12. Caroni P. New EMBO members' review: actin cytoskeleton regulation through modulation of PI(4,5)P(2) rafts. EMBO J. 20 (2001) 4332-4336
13. Lanier L.M., and Gertler F.B. Actin cytoskeleton: thinking globally, actin' locally. Curr. Biol. 10 (2000) R655-R657
14. Arbuzova A., Wang L., Wang J., Hangyas-Mihalyne G., Murray D., Honig B., and McLaughlin S. Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS. Biochemistry 39 (2000) 10330-10339
15. Seykora J.T., Myat M.M., Allen L.A., Ravetch J.V., and Aderem A. Molecular determinants of the myristoyl-electrostatic switch of MARCKS. J. Biol. Chem. 271 (1996) 18797-18802
16. Laux T., Fukami K., Thelen M., Golub T., Frey D., and Caroni P. GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J. Cell Biol. 149 (2000) 1455-1472
17. Zhang W., Crocker E., McLaughlin S., and Smith S.O. Binding of peptides with basic and aromatic residues to bilayer membranes: phenylalanine in the myristoylated alanine-rich C kinase substrate effector domain penetrates into the hydrophobic core of the bilayer. J. Biol. Chem. 278 (2003) 21459-21466
18. Sundaram M., Cook H.W., and Byers D.M. The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components. Biochem. Cell. Biol. 82 (2004) 191-200
19. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., and Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103 (2006) 2257-2261
20. Karginov F.V., Conaco C., Xuan Z., Schmidt B.H., Parker J.S., Mandel G., and Hannon G.J. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. USA 104 (2007) 19291-19296
21. Ding Z., Lambrechts A., Parepally M., and Roy P. Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis. J. Cell Sci. 119 (2006) 4127-4137
22. Doench J.G., and Sharp P.A. Specificity of microRNA target selection in translational repression. Genes Dev. 18 (2004) 504-511
23. Rombouts K., Lottini B., Caligiuri A., Liotta F., Mello T., Carloni V., Marra F., and Pinzani M. MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells. Exp. Cell Res. 314 (2008) 1444-1454
24. Chan J.A., Krichevsky A.M., and Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65 (2005) 6029-6033
25. Yamaguchi T., Iijima T., Mori T., Takahashi K., Matsumoto H., Miyamoto H., Hishima T., and Miyaki M. Accumulation profile of frameshift mutations during development and progression of colorectal cancer from patients with hereditary nonpolyposis colorectal cancer. Dis. Colon Rectum. 49 (2006) 399-406
26. Kim N.G., Rhee H., Li L.S., Kim H., Lee J.S., Kim J.H., Kim N.K., and Kim H. Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability. Oncogene 21 (2002) 5081-5087
27. Masaki T., Tokuda M., Yoshida S., Nakai S., Morishita A., Uchida N., Funaki T., Kita Y., Funakoshi F., Nonomura T., Himoto T., Deguchi A., Kimura Y., Izuishi K., Wakabayashi H., Usuki H., Yoshiji H., Watanabe S., Kurokohchi K., and Kuriyama S. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Int. J. Oncol. 26 (2005) 661-671
28. Stensman H., and Larsson C. Protein kinase Cepsilon is important for migration of neuroblastoma cells. BMC Cancer 8 (2008) 365